OtherBASIC SCIENCE INVESTIGATIONS
Favorable Biokinetic and Tumor-Targeting Properties of 99mTc-Labeled Glucosamino RGD and Effect of Paclitaxel Therapy
Kyung-Ho Jung, Kyung-Han Lee, Jin-Young Paik, Bong-Ho Ko, Jun-Sang Bae, Byung Chul Lee, Hyun Ju Sung, Dong Hyun Kim, Yearn Seong Choe and Dae Yoon Chi
Journal of Nuclear Medicine December 2006, 47 (12) 2000-2007;
Kyung-Ho Jung
Kyung-Han Lee
Jin-Young Paik
Bong-Ho Ko
Jun-Sang Bae
Byung Chul Lee
Hyun Ju Sung
Dong Hyun Kim
Yearn Seong Choe
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 3
March 1, 2024
Favorable Biokinetic and Tumor-Targeting Properties of 99mTc-Labeled Glucosamino RGD and Effect of Paclitaxel Therapy
Kyung-Ho Jung, Kyung-Han Lee, Jin-Young Paik, Bong-Ho Ko, Jun-Sang Bae, Byung Chul Lee, Hyun Ju Sung, Dong Hyun Kim, Yearn Seong Choe, Dae Yoon Chi
Journal of Nuclear Medicine Dec 2006, 47 (12) 2000-2007;
Favorable Biokinetic and Tumor-Targeting Properties of 99mTc-Labeled Glucosamino RGD and Effect of Paclitaxel Therapy
Kyung-Ho Jung, Kyung-Han Lee, Jin-Young Paik, Bong-Ho Ko, Jun-Sang Bae, Byung Chul Lee, Hyun Ju Sung, Dong Hyun Kim, Yearn Seong Choe, Dae Yoon Chi
Journal of Nuclear Medicine Dec 2006, 47 (12) 2000-2007;
Related Articles
Cited By...
- Imaging Integrin {alpha}v{beta}3 on Blood Vessels with 111In-RGD2 in Head and Neck Tumor Xenografts
- Integrin {alpha}v{beta}3 Imaging of Radioactive Iodine-Refractory Thyroid Cancer Using 99mTc-3PRGD2
- 99mTc-Labeled Tricarbonyl His-CNA35 as an Imaging Agent for the Detection of Tumor Vasculature
- Monitoring Tumor Response to Antiangiogenic Sunitinib Therapy with 18F-Fluciclatide, an 18F-Labeled αV{beta}3-Integrin and αV{beta}5-Integrin Imaging Agent
- PET of αv{beta}3-Integrin and αv{beta}5-Integrin Expression with 18F-Fluciclatide for Assessment of Response to Targeted Therapy: Ready for Prime Time?
- 18F-FPPRGD2 and 18F-FDG PET of Response to Abraxane Therapy
- Use of a Novel Arg-Gly-Asp Radioligand, 18F-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy
- 18F-Labeled BBN-RGD Heterodimer for Prostate Cancer Imaging
- 64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor {alpha}v{beta}3 Integrin Expression